Clinical Trials · NCT06378866
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 532
- Start date
- Jun 2024
- Locations
- 3 sites, United States
- Primary endpoint
- Modified radiographic progression-free survival (mrPFS) (Groups A & B)